Economic portfolio
ICICI Prudential Nifty Healthcare ETF
ICICI ICICI Prudential Mutual Fund Jul 2026 — Sep 2026 3 months
Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →
Days to sell half: 0.3 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →
Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.
How concentrated it has been
3 priced months, Jul 2026 to Sep 2026 · at each month’s NSE closes
Top 10 holdings, share of equity
75.8% now · highest 77.7%, lowest 75.8%
Companies held
20 now · largest single holding 17.0% of equity
Sector mix
Share of the equity shown · NSE industry
Funds most like this one
Overlap of disclosed equity · the smaller share of each company both hold, added up
- Axis NIFTY Healthcare ETFAxis · 20 shared100.0%
- DSP Nifty Healthcare Index FundDSP · 20 shared100.0%
- DSP Nifty Healthcare ETFDSP · 20 shared100.0%
- ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 20 shared99.9%
- EODWHFEdelweiss · 18 shared91.8%
- Nippon India Nifty Pharma ETFNippon India · 16 shared81.1%
- ICICI Prudential Nifty Pharma Index FundICICI Prudential · 16 shared81.1%
- Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared79.8%
Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.
What changed in Sep 2026
This portfolio’s consecutive disclosures · evidenced adjustments applied
New positions
Complete exits
Largest increases
- 01 Sun Pharmaceutical Industries Limited+0.3% +735
- 02 Max Healthcare Institute Limited+0.3% +513
- 03 Dr. Reddy's Laboratories Limited+0.4% +484
- 04 Cipla Limited+0.4% +409
- 05 Alkem Laboratories Limited+3.4% +406
- 06 Laurus Labs Limited+0.4% +354
- 07 Fortis Healthcare Limited+0.3% +352
- 08 Torrent Pharmaceuticals Limited+0.7% +199
- 09 Lupin Limited+0.4% +182
- 10 Aurobindo Pharma Limited+0.2% +106
Largest reductions
Share quantities, not market values or cash flows.
Holdings by value
Sep 2026 · largest 100 · share of the equity shown
| Company | Sector | Size | Share of equity | Value | Shares held | Held since |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Healthcare | Large Cap | 17.00% | 39.34 Cr | 0.02 Cr | by Jul 2026 (3 mo+) |
| Divi's Laboratories Limited | Healthcare | Large Cap | 10.44% | 24.15 Cr | 25,993 | by Jul 2026 (3 mo+) |
| Apollo Hospitals Enterprise Limited | Healthcare | Large Cap | 7.43% | 17.19 Cr | 21,048 | by Jul 2026 (3 mo+) |
| Laurus Labs Limited | Healthcare | Mid Cap | 6.82% | 15.77 Cr | 79,659 | by Jul 2026 (3 mo+) |
| Cipla Limited | Healthcare | Large Cap | 6.70% | 15.49 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
| Dr. Reddy's Laboratories Limited | Healthcare | Large Cap | 6.65% | 15.38 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
| Torrent Pharmaceuticals Limited | Healthcare | Large Cap | 6.24% | 14.45 Cr | 30,098 | by Jul 2026 (3 mo+) |
| Max Healthcare Institute Limited | Healthcare | Large Cap | 6.12% | 14.15 Cr | 0.02 Cr | by Jul 2026 (3 mo+) |
| Lupin Limited | Healthcare | Mid Cap | 4.36% | 10.09 Cr | 49,682 | by Jul 2026 (3 mo+) |
| Aurobindo Pharma Limited | Healthcare | Mid Cap | 4.09% | 9.45 Cr | 56,526 | by Jul 2026 (3 mo+) |
| Fortis Healthcare Limited | Healthcare | Mid Cap | 3.55% | 8.21 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
| Glenmark Pharmaceuticals Limited | Healthcare | Mid Cap | 3.11% | 7.19 Cr | 30,795 | by Jul 2026 (3 mo+) |
| Alkem Laboratories Limited | Healthcare | Mid Cap | 2.75% | 6.37 Cr | 12,333 | by Jul 2026 (3 mo+) |
| Zydus Lifesciences Limited | Healthcare | Mid Cap | 2.55% | 5.89 Cr | 50,684 | by Jul 2026 (3 mo+) |
| Mankind Pharma Limited | Healthcare | Mid Cap | 2.51% | 5.80 Cr | 23,178 | by Jul 2026 (3 mo+) |
| IPCA Laboratories Limited | Healthcare | Mid Cap | 2.37% | 5.48 Cr | 28,415 | by Jul 2026 (3 mo+) |
| Biocon Limited | Healthcare | Mid Cap | 2.28% | 5.28 Cr | 0.01 Cr | by Jul 2026 (3 mo+) |
| Gland Pharma Limited | Healthcare | Small Cap | 2.04% | 4.73 Cr | 16,300 | Sep 2026 (1 mo) |
| Krishna Institute of Medical Sciences Limited | Healthcare | Small Cap | 1.76% | 4.07 Cr | 54,583 | Sep 2026 (1 mo) |
| Abbott India Limited | Healthcare | Mid Cap | 1.25% | 2.89 Cr | 1,065 | by Jul 2026 (3 mo+) |
Half of its current holdings have been held for 3 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.
Recent position changes
Latest 100 company-month records · evidenced adjustments applied
| Company | Month | Activity | Adjusted change |
|---|---|---|---|
| Piramal Pharma Limited | Sep 2026 | ▼ Complete exit | -0.01 Cr |
| Krishna Institute of Medical Sciences Limited | Sep 2026 | ▲ New position | +54,583 |
| Syngene International Limited | Sep 2026 | ▼ Complete exit | -38,752 |
| Gland Pharma Limited | Sep 2026 | ▲ New position | +16,300 |
| Biocon Limited | Sep 2026 | ▼ Reducing | -2,879 |
| Sun Pharmaceutical Industries Limited | Sep 2026 | ▲ Increasing | +735 |
| Max Healthcare Institute Limited | Sep 2026 | ▲ Increasing | +513 |
| Dr. Reddy's Laboratories Limited | Sep 2026 | ▲ Increasing | +484 |
| Cipla Limited | Sep 2026 | ▲ Increasing | +409 |
| Alkem Laboratories Limited | Sep 2026 | ▲ Increasing | +406 |
| Laurus Labs Limited | Sep 2026 | ▲ Increasing | +354 |
| Fortis Healthcare Limited | Sep 2026 | ▲ Increasing | +352 |
| Zydus Lifesciences Limited | Sep 2026 | ▼ Reducing | -312 |
| Torrent Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +199 |
| Lupin Limited | Sep 2026 | ▲ Increasing | +182 |
| Aurobindo Pharma Limited | Sep 2026 | ▲ Increasing | +106 |
| Glenmark Pharmaceuticals Limited | Sep 2026 | ▲ Increasing | +105 |
| Mankind Pharma Limited | Sep 2026 | ▲ Increasing | +102 |
| IPCA Laboratories Limited | Sep 2026 | ▲ Increasing | +102 |
| Divi's Laboratories Limited | Sep 2026 | ▲ Increasing | +89 |
| Apollo Hospitals Enterprise Limited | Sep 2026 | ▲ Increasing | +72 |
| Abbott India Limited | Sep 2026 | ▲ Increasing | +3 |
| Sun Pharmaceutical Industries Limited | Aug 2026 | ▼ Reducing | -418 |
| Max Healthcare Institute Limited | Aug 2026 | ▼ Reducing | -291 |
| Biocon Limited | Aug 2026 | ▼ Reducing | -279 |
| Piramal Pharma Limited | Aug 2026 | ▼ Reducing | -244 |
| Dr. Reddy's Laboratories Limited | Aug 2026 | ▼ Reducing | -239 |
| Cipla Limited | Aug 2026 | ▼ Reducing | -219 |
| Fortis Healthcare Limited | Aug 2026 | ▼ Reducing | -204 |
| Laurus Labs Limited | Aug 2026 | ▼ Reducing | -153 |
| Aurobindo Pharma Limited | Aug 2026 | ▼ Reducing | -107 |
| Lupin Limited | Aug 2026 | ▼ Reducing | -98 |
| Zydus Lifesciences Limited | Aug 2026 | ▼ Reducing | -95 |
| Syngene International Limited | Aug 2026 | ▼ Reducing | -72 |
| Glenmark Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -61 |
| Torrent Pharmaceuticals Limited | Aug 2026 | ▼ Reducing | -59 |
| IPCA Laboratories Limited | Aug 2026 | ▼ Reducing | -52 |
| Divi's Laboratories Limited | Aug 2026 | ▼ Reducing | -51 |
| Mankind Pharma Limited | Aug 2026 | ▼ Reducing | -46 |
| Apollo Hospitals Enterprise Limited | Aug 2026 | ▼ Reducing | -42 |
| Alkem Laboratories Limited | Aug 2026 | ▼ Reducing | -24 |
| Abbott India Limited | Aug 2026 | ▼ Reducing | -2 |
Changes compare consecutive month-end disclosures for this portfolio only.